SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 254 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $94,758 | -47.0% | 3,437 | -42.2% | 0.02% | -61.5% |
| Q2 2023 | $178,797 | -16.7% | 5,948 | +0.4% | 0.05% | -24.6% |
| Q1 2023 | $214,699 | -4.8% | 5,926 | -6.2% | 0.07% | -8.0% |
| Q4 2022 | $225,470 | +77.5% | 6,321 | +68.5% | 0.08% | +19.0% |
| Q3 2022 | $127,000 | -17.5% | 3,752 | -29.6% | 0.06% | -33.7% |
| Q2 2022 | $154,000 | +40.0% | 5,327 | +56.9% | 0.10% | +72.7% |
| Q1 2022 | $110,000 | +77.4% | 3,396 | +59.1% | 0.06% | +89.7% |
| Q4 2021 | $62,000 | +5.1% | 2,135 | -2.9% | 0.03% | -23.7% |
| Q3 2021 | $59,000 | +5.4% | 2,198 | +20.0% | 0.04% | +8.6% |
| Q2 2021 | $56,000 | – | 1,832 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 335,000 | $8,934,000 | 13.38% |
| ASHFORD CAPITAL MANAGEMENT INC | 1,016,665 | $27,114,000 | 2.46% |
| Bruce & Co., Inc. | 402,105 | $10,724,000 | 2.28% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 297,500 | $7,934,000 | 1.91% |
| ARMISTICE CAPITAL, LLC | 3,900,000 | $104,013,000 | 1.76% |
| Bridge City Capital, LLC | 108,884 | $2,904,000 | 1.32% |
| S&T BANK/PA | 316,098 | $8,430,000 | 1.31% |
| Kent Lake Capital LLC | 100,000 | $2,667,000 | 1.15% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 331,140 | $8,832,000 | 1.02% |
| Prairiewood Capital, LLC | 45,297 | $1,208,000 | 0.99% |